The OBA is a branch of the Canadian Bar Association (CBA), an organization of lawyers formed to provide support by the profession to the profession so that it may render better service to its members and the public. The association provides lawyers with opportunities to become more efficient and effective, to further their professional education and to keep abreast of current developments within the profession, nationally and provincially.
Throughout their two-year term, Council members:
act as ambassadors and liaisons for the OBA within their region
identify issues and opportunities and provide advice to the Board on how to address them
elect the Board of Directors (the decision making body of the Association) each year
are expected to bring forward general and regional issues of importance to members and to the profession, including:
Identification of issues in the region (practice or professional) that would benefit from OBA advocacy
Issues related to the operation or administration of the judicial system
Regional professional development needs
Issues related to the presence of the Association in the region
For more information about the OBA governance structure please visit their web site here.… Read More
This is the fourth year Canadian Lawyer has run their Readers’ Choice Awards. The program is designed to give a voice to their readers to identify which vendors and suppliers are the best at what they do.
Voting is open until June 25th and winners will be announced in a special feature in the October issue of Canadian Lawyer.
In Schwoob v. Bayer Inc., 2018 ONSC 166 (CanLII), a product liability class action, the Ontario Superior Court of Justice ordered two non-parties affiliated with the defendant corporation to produce 2,900 documents that they had produced in a parallel U.S. class action proceeding.
The plaintiffs brought a claim against Bayer Inc. (“Bayer Canada”) and two affiliated companies, Bayer Healthcare Pharmaceuticals Inc. (“Bayer U.S.”) and Bayer Pharma AG (“Bayer Pharma”), in 2010, on behalf of women in Ontario who had taken certain prescription oral contraceptives. The claim alleged negligence in the design, testing, distribution, marketing and sale of the contraceptives, as well as failure to adequately warn of the risk of adverse consequences. … Read More